Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,323 | 14,829 | 3,957 | 8,985 | 1,579 |
| Receivables | 361 | 297 | 30 | 16 | 3,850 |
| TOTAL | $54,299 | $15,597 | $5,059 | $10,019 | $7,090 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 100 | 128 | 166 |
| Intangibles | 0 | 219 | 237 | 256 | 284 |
| Other Non-Current Assets | 274 | 201 | 211 | 0 | 0 |
| TOTAL | $274 | $420 | $548 | $383 | $450 |
| Total Assets | $54,573 | $16,017 | $5,607 | $10,403 | $7,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,709 | 2,816 | 2,027 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,566 | 524 | 1,641 | 3,539 | 2,091 |
| Accrued Expenses | 300 | 5 | 110 | 91 | N/A |
| TOTAL | $5,575 | $3,344 | $3,777 | $3,630 | $2,091 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,501 | 5,933 | N/A | N/A |
| Other Non-Current Liabilities | 17 | 20 | 171 | 7,310 | 993 |
| TOTAL | $17 | $3,521 | $6,104 | $7,310 | $993 |
| Total Liabilities | $5,591 | $6,865 | $9,881 | $10,939 | $3,084 |
| Shareholders' Equity | |||||
| Common Shares | 78,545 | 40,206 | 25,980 | 25,975 | 19,419 |
| Retained earnings | -57,525 | -44,369 | -32,740 | -28,241 | -15,626 |
| Other shareholders' equity | -2,077 | 13,315 | 2,486 | 1,729 | 662 |
| TOTAL | $48,982 | $9,152 | $-4,274 | $-537 | $4,456 |
| Total Liabilities And Equity | $54,573 | $16,017 | $5,607 | $10,403 | $7,540 |